Budesonide, fluticasone propionate, and azithromycin do not modulate the membrane vesicle release by THP-1 macrophages and respiratory pathogens during macrophage infection

Patients with more severe chronic obstructive pulmonary disease frequently experience exacerbations and it is estimated that up to 50% of these exacerbations are associated with bacterial infections. The mainstay treatment for these infection-related exacerbations constitutes the administration of g...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Inflammopharmacology
Autors principals: Volgers, Charlotte, Grauls, Gert E., Hellebrand, Pauline H. M., Savelkoul, Paul H. M., Stassen, Frank R. M.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5671549/
https://ncbi.nlm.nih.gov/pubmed/28528362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10787-017-0359-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars